glp 1 and anesthesia Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists ASA Advises No Longer Holding

When Madeson shared his data with Knudsen in 1995, she realised that it rang a bell because she had noticed that both normal and obese rates experienced a lasting and reversible weight loss when given one of her early GLP-1 analogues

For the first time in the history of obesity medications we see weight loss efficacy of a magnitude that might raise concern about excessive loss of lean body tissue due to the initial pronounced reduction in energy intake and subsequent risk of protein deficiency

[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Holst J

Follow-up visits help the plan adjust instead of leaving patients alone with questions

Sometimes this normal effect can develop into gastroparesis